ID   MBL1_RAT                Reviewed;         238 AA.
AC   P19999;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   03-AUG-2022, entry version 185.
DE   RecName: Full=Mannose-binding protein A;
DE            Short=MBP-A {ECO:0000303|PubMed:3009480};
DE   AltName: Full=Mannan-binding protein;
DE   Flags: Precursor;
GN   Name=Mbl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=3009480; DOI=10.1016/s0021-9258(19)62698-0;
RA   Drickamer K., Dordal M.S., Reynolds L.;
RT   "Mannose-binding proteins isolated from rat liver contain carbohydrate-
RT   recognition domains linked to collagenous tails. Complete primary
RT   structures and homology with pulmonary surfactant apoprotein.";
RL   J. Biol. Chem. 261:6878-6887(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=3029088; DOI=10.1016/s0021-9258(18)61545-5;
RA   Drickamer K., McCreary V.;
RT   "Exon structure of a mannose-binding protein gene reflects its evolutionary
RT   relationship to the asialoglycoprotein receptor and nonfibrillar
RT   collagens.";
RL   J. Biol. Chem. 262:2582-2589(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 18-42, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=3584121; DOI=10.1016/s0021-9258(18)47587-4;
RA   Ikeda K., Sannoh T., Kawasaki N., Kawasaki T., Yamashina I.;
RT   "Serum lectin with known structure activates complement through the
RT   classical pathway.";
RL   J. Biol. Chem. 262:7451-7454(1987).
RN   [5]
RP   INTERACTION WITH MASP1 AND MASP2.
RC   TISSUE=Liver;
RX   PubMed=10913141; DOI=10.1074/jbc.m004030200;
RA   Wallis R., Dodd R.B.;
RT   "Interaction of mannose-binding protein with associated serine proteases:
RT   effects of naturally occurring mutations.";
RL   J. Biol. Chem. 275:30962-30969(2000).
RN   [6]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION, OLIGOMERIZATION, MUTAGENESIS OF
RP   ARG-40; GLY-42; LYS-44; GLY-45 AND LYS-47, AND HYDROXYLATION AT LYS-44 AND
RP   LYS-47.
RX   PubMed=10903744; DOI=10.4049/jimmunol.165.3.1403;
RA   Heise C.T., Nicholls J.R., Leamy C.E., Wallis R.;
RT   "Impaired secretion of rat mannose-binding protein resulting from mutations
RT   in the collagen-like domain.";
RL   J. Immunol. 165:1403-1409(2000).
RN   [7]
RP   SUBUNIT, SUBCELLULAR LOCATION, HYDROXYLATION AT LYS-44; LYS-47; PRO-50;
RP   LYS-79 AND LYS-82, GLYCOSYLATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25419660; DOI=10.1371/journal.pone.0113498;
RA   Risteli M., Ruotsalainen H., Bergmann U., Venkatraman Girija U., Wallis R.,
RA   Myllylae R.;
RT   "Lysyl hydroxylase 3 modifies lysine residues to facilitate oligomerization
RT   of mannan-binding lectin.";
RL   PLoS ONE 9:E113498-E113498(2014).
RN   [8] {ECO:0007744|PDB:1MSB}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 124-238, AND DISULFIDE BONDS.
RX   PubMed=1721241; DOI=10.1126/science.1721241;
RA   Weis W.I., Kahn R., Fourme R., Drickamer K., Hendrickson W.A.;
RT   "Structure of the calcium-dependent lectin domain from a rat mannose-
RT   binding protein determined by MAD phasing.";
RL   Science 254:1608-1615(1991).
RN   [9] {ECO:0007744|PDB:2MSB}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 124-238 IN COMPLEX WITH CALCIUM
RP   AND CARBOHYDRATE, FUNCTION, AND DISULFIDE BONDS.
RX   PubMed=1436090; DOI=10.1038/360127a0;
RA   Weis W.I., Drickamer K., Hendrickson W.A.;
RT   "Structure of a C-type mannose-binding protein complexed with an
RT   oligosaccharide.";
RL   Nature 360:127-134(1992).
RN   [10] {ECO:0007744|PDB:1RTM}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 90-238 IN COMPLEX WITH CALCIUM,
RP   SUBUNIT, DOMAIN, AND DISULFIDE BONDS.
RX   PubMed=7704532; DOI=10.1016/s0969-2126(94)00124-3;
RA   Weis W.I., Drickamer K.;
RT   "Trimeric structure of a C-type mannose-binding protein.";
RL   Structure 2:1227-1240(1994).
RN   [11] {ECO:0007744|PDB:1KMB, ECO:0007744|PDB:2KMB, ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 90-238 OF MUTANT 228-LYS--LYS-230
RP   IN COMPLEXES WITH CALCIUM AND CARBOHYDRATE, FUNCTION, SUBUNIT, DOMAIN,
RP   DISULFIDE BONDS, AND MUTAGENESIS OF 228-ALA--HIS-230.
RX   PubMed=9033386; DOI=10.1021/bi962564e;
RA   Ng K.K., Weis W.I.;
RT   "Structure of a selectin-like mutant of mannose-binding protein complexed
RT   with sialylated and sulfated Lewis(x) oligosaccharides.";
RL   Biochemistry 36:979-988(1997).
RN   [12] {ECO:0007744|PDB:1BUU}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 75-238, AND DISULFIDE BONDS.
RX   PubMed=9922165; DOI=10.1021/bi981972a;
RA   Ng K.K.-S., Park-Snyder S., Weis W.I.;
RT   "Ca2+-dependent structural changes in C-type mannose-binding proteins.";
RL   Biochemistry 37:17965-17976(1998).
RN   [13] {ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU, ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW, ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY, ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0, ECO:0007744|PDB:1KX1}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 90-238 IN COMPLEXES WITH CALCIUM
RP   AND CARBOHYDRATE, FUNCTION, SUBUNIT, DOMAIN, AND DISULFIDE BONDS.
RX   PubMed=11850428; DOI=10.1074/jbc.m200493200;
RA   Ng K.K., Kolatkar A.R., Park-Snyder S., Feinberg H., Clark D.A.,
RA   Drickamer K., Weis W.I.;
RT   "Orientation of bound ligands in mannose-binding proteins. Implications for
RT   multivalent ligand recognition.";
RL   J. Biol. Chem. 277:16088-16095(2002).
CC   -!- FUNCTION: Calcium-dependent lectin (PubMed:1436090, PubMed:9033386,
CC       PubMed:11850428). Plays a role in the innate immune response by binding
CC       mannose, fucose and N-acetylglucosamine moieties on different
CC       microorganisms and mediating activation of the lectin complement
CC       pathway (PubMed:3584121). Binds to late apoptotic cells, as well as to
CC       apoptotic blebs and to necrotic cells, but not to early apoptotic
CC       cells, facilitating their uptake by macrophages (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:11850428, ECO:0000269|PubMed:1436090,
CC       ECO:0000269|PubMed:3584121, ECO:0000269|PubMed:9033386}.
CC   -!- SUBUNIT: Homotrimer (PubMed:7704532, PubMed:9033386, PubMed:11850428,
CC       PubMed:25419660). Forms higher oligomeric complexes formed by the
CC       association of two, three or more homotrimers (PubMed:10903744,
CC       PubMed:25419660). Oligomerization occurs in the endoplasmic reticulum
CC       (By similarity). Interacts with MASP1 and MASP2 (PubMed:10913141).
CC       {ECO:0000250, ECO:0000269|PubMed:10903744, ECO:0000269|PubMed:10913141,
CC       ECO:0000269|PubMed:11850428, ECO:0000269|PubMed:25419660,
CC       ECO:0000269|PubMed:7704532, ECO:0000269|PubMed:9033386}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10903744,
CC       ECO:0000269|PubMed:25419660, ECO:0000269|PubMed:3584121}.
CC       Note=According to PubMed:10903744, long retention times in the
CC       endoplasmic reticulum and the Golgi apparatus that have been observed
CC       in former studies may reflect the abnormal physiology of the hepatoma
CC       cells used.
CC   -!- TISSUE SPECIFICITY: Detected in blood serum (at protein level).
CC       {ECO:0000269|PubMed:3584121}.
CC   -!- DOMAIN: The helical collagen-like domains from three protein chains
CC       assemble into a coiled coil and mediate trimerization.
CC       {ECO:0000269|PubMed:11850428, ECO:0000269|PubMed:7704532,
CC       ECO:0000269|PubMed:9033386}.
CC   -!- PTM: Hydroxylated on lysine and proline residues within the collagen-
CC       like domain. {ECO:0000269|PubMed:10903744,
CC       ECO:0000269|PubMed:25419660}.
CC   -!- PTM: O-glycosylated. O-linked glycans on hydroxylysine residues consist
CC       of Glc-Gal disaccharides bound to the oxygen atom of post-
CC       translationally added hydroxyl groups. {ECO:0000269|PubMed:10903744,
CC       ECO:0000269|PubMed:25419660}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Mannose-binding protein A;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_rat_Ctlect_00135";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M14105; AAA98781.1; -; Genomic_DNA.
DR   EMBL; M14104; AAA98781.1; JOINED; Genomic_DNA.
DR   EMBL; BC088159; AAH88159.1; -; mRNA.
DR   PIR; B24791; LNRTMA.
DR   RefSeq; NP_036731.2; NM_012599.2.
DR   PDB; 1AFA; X-ray; 2.00 A; 1/2/3=90-238.
DR   PDB; 1AFB; X-ray; 1.90 A; 1/2/3=90-238.
DR   PDB; 1AFD; X-ray; 2.00 A; 1/2/3=90-238.
DR   PDB; 1BCH; X-ray; 2.00 A; 1/2/3=90-238.
DR   PDB; 1BCJ; X-ray; 2.10 A; 1/2/3=90-238.
DR   PDB; 1BUU; X-ray; 1.90 A; A=75-238.
DR   PDB; 1FIF; X-ray; 1.95 A; A/B/C=90-238.
DR   PDB; 1FIH; X-ray; 1.95 A; A/B/C=90-238.
DR   PDB; 1KMB; X-ray; 2.10 A; 1/2/3=90-238.
DR   PDB; 1KWT; X-ray; 1.95 A; A/B/C=90-238.
DR   PDB; 1KWU; X-ray; 1.95 A; A/B/C=90-238.
DR   PDB; 1KWV; X-ray; 2.00 A; A/B/C=90-238.
DR   PDB; 1KWW; X-ray; 1.90 A; A/B/C=90-238.
DR   PDB; 1KWX; X-ray; 2.00 A; A/B/C=90-238.
DR   PDB; 1KWY; X-ray; 2.00 A; A/B/C=90-238.
DR   PDB; 1KWZ; X-ray; 1.90 A; A/B/C=90-238.
DR   PDB; 1KX0; X-ray; 2.00 A; A/B/C=90-238.
DR   PDB; 1KX1; X-ray; 2.80 A; A/B/C/D/E/F=90-238.
DR   PDB; 1MSB; X-ray; 2.30 A; A/B=124-238.
DR   PDB; 1RTM; X-ray; 1.80 A; 1/2/3=90-238.
DR   PDB; 1YTT; X-ray; 1.80 A; A/B=124-238.
DR   PDB; 2KMB; X-ray; 2.00 A; 1/2/3=90-238.
DR   PDB; 2MSB; X-ray; 1.70 A; A/B=124-238.
DR   PDB; 3KMB; X-ray; 1.95 A; 1/2/3=90-238.
DR   PDB; 4KMB; X-ray; 2.00 A; 1/2/3=90-238.
DR   PDBsum; 1AFA; -.
DR   PDBsum; 1AFB; -.
DR   PDBsum; 1AFD; -.
DR   PDBsum; 1BCH; -.
DR   PDBsum; 1BCJ; -.
DR   PDBsum; 1BUU; -.
DR   PDBsum; 1FIF; -.
DR   PDBsum; 1FIH; -.
DR   PDBsum; 1KMB; -.
DR   PDBsum; 1KWT; -.
DR   PDBsum; 1KWU; -.
DR   PDBsum; 1KWV; -.
DR   PDBsum; 1KWW; -.
DR   PDBsum; 1KWX; -.
DR   PDBsum; 1KWY; -.
DR   PDBsum; 1KWZ; -.
DR   PDBsum; 1KX0; -.
DR   PDBsum; 1KX1; -.
DR   PDBsum; 1MSB; -.
DR   PDBsum; 1RTM; -.
DR   PDBsum; 1YTT; -.
DR   PDBsum; 2KMB; -.
DR   PDBsum; 2MSB; -.
DR   PDBsum; 3KMB; -.
DR   PDBsum; 4KMB; -.
DR   AlphaFoldDB; P19999; -.
DR   SMR; P19999; -.
DR   STRING; 10116.ENSRNOP00000015723; -.
DR   UniLectin; P19999; -.
DR   GlyGen; P19999; 4 sites.
DR   PaxDb; P19999; -.
DR   Ensembl; ENSRNOT00000015723; ENSRNOP00000015723; ENSRNOG00000011706.
DR   GeneID; 24548; -.
DR   KEGG; rno:24548; -.
DR   UCSC; RGD:3055; rat.
DR   CTD; 17194; -.
DR   RGD; 3055; Mbl1.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000154368; -.
DR   HOGENOM; CLU_049894_3_0_1; -.
DR   InParanoid; P19999; -.
DR   OMA; TCSVVAC; -.
DR   OrthoDB; 1222552at2759; -.
DR   PhylomeDB; P19999; -.
DR   TreeFam; TF330481; -.
DR   EvolutionaryTrace; P19999; -.
DR   PRO; PR:P19999; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000011706; Expressed in liver and 5 other tissues.
DR   Genevisible; P19999; RN.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0120153; F:calcium-dependent carbohydrate binding; IDA:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0005537; F:mannose binding; IDA:UniProtKB.
DR   GO; GO:0070492; F:oligosaccharide binding; IDA:UniProtKB.
DR   GO; GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:RGD.
DR   GO; GO:0030247; F:polysaccharide binding; IDA:RGD.
DR   GO; GO:0002020; F:protease binding; IDA:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0001867; P:complement activation, lectin pathway; IDA:RGD.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISO:RGD.
DR   GO; GO:0051873; P:killing by host of symbiont cells; ISO:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISO:RGD.
DR   GO; GO:0070207; P:protein homotrimerization; IDA:UniProtKB.
DR   CDD; cd03591; CLECT_collectin_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR033990; Collectin_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR042129; Mannose-binding_protein_A.
DR   PANTHER; PTHR24024:SF35; PTHR24024:SF35; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Collagen; Complement activation lectin pathway;
KW   Complement pathway; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Hydroxylation; Immunity; Innate immunity; Lectin;
KW   Mannose-binding; Metal-binding; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000269|PubMed:3584121"
FT   CHAIN           18..238
FT                   /note="Mannose-binding protein A"
FT                   /id="PRO_0000017414"
FT   DOMAIN          39..88
FT                   /note="Collagen-like"
FT   DOMAIN          143..238
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          38..87
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          202..210
FT                   /note="Calcium-dependent carbohydrate binding"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:9033386"
FT   BINDING         178
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1AFA,
FT                   ECO:0007744|PDB:1AFB, ECO:0007744|PDB:1AFD,
FT                   ECO:0007744|PDB:1BCH, ECO:0007744|PDB:1BCJ,
FT                   ECO:0007744|PDB:1FIF, ECO:0007744|PDB:1FIH,
FT                   ECO:0007744|PDB:1KMB, ECO:0007744|PDB:1KWT,
FT                   ECO:0007744|PDB:1KWU, ECO:0007744|PDB:1KWV,
FT                   ECO:0007744|PDB:1KWW, ECO:0007744|PDB:1KWX,
FT                   ECO:0007744|PDB:1KWY, ECO:0007744|PDB:1KWZ,
FT                   ECO:0007744|PDB:1KX0, ECO:0007744|PDB:1KX1,
FT                   ECO:0007744|PDB:1RTM, ECO:0007744|PDB:2KMB,
FT                   ECO:0007744|PDB:2MSB, ECO:0007744|PDB:3KMB,
FT                   ECO:0007744|PDB:4KMB"
FT   BINDING         182
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1AFA,
FT                   ECO:0007744|PDB:1AFB, ECO:0007744|PDB:1AFD,
FT                   ECO:0007744|PDB:1BCH, ECO:0007744|PDB:1BCJ,
FT                   ECO:0007744|PDB:1FIF, ECO:0007744|PDB:1FIH,
FT                   ECO:0007744|PDB:1KMB, ECO:0007744|PDB:1KWT,
FT                   ECO:0007744|PDB:1KWU, ECO:0007744|PDB:1KWV,
FT                   ECO:0007744|PDB:1KWW, ECO:0007744|PDB:1KWX,
FT                   ECO:0007744|PDB:1KWY, ECO:0007744|PDB:1KWZ,
FT                   ECO:0007744|PDB:1KX0, ECO:0007744|PDB:1KX1,
FT                   ECO:0007744|PDB:1RTM, ECO:0007744|PDB:2KMB,
FT                   ECO:0007744|PDB:2MSB, ECO:0007744|PDB:3KMB,
FT                   ECO:0007744|PDB:4KMB"
FT   BINDING         202
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1KMB,
FT                   ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU,
FT                   ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW,
FT                   ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY,
FT                   ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0,
FT                   ECO:0007744|PDB:1KX1, ECO:0007744|PDB:1RTM,
FT                   ECO:0007744|PDB:2KMB, ECO:0007744|PDB:2MSB,
FT                   ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB"
FT   BINDING         204
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1KMB,
FT                   ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU,
FT                   ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW,
FT                   ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY,
FT                   ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0,
FT                   ECO:0007744|PDB:1KX1, ECO:0007744|PDB:1RTM,
FT                   ECO:0007744|PDB:2KMB, ECO:0007744|PDB:2MSB,
FT                   ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB"
FT   BINDING         205
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1AFA,
FT                   ECO:0007744|PDB:1AFB, ECO:0007744|PDB:1AFD,
FT                   ECO:0007744|PDB:1BCH, ECO:0007744|PDB:1BCJ,
FT                   ECO:0007744|PDB:1FIF, ECO:0007744|PDB:1FIH,
FT                   ECO:0007744|PDB:1KMB, ECO:0007744|PDB:1KWT,
FT                   ECO:0007744|PDB:1KWU, ECO:0007744|PDB:1KWV,
FT                   ECO:0007744|PDB:1KWW, ECO:0007744|PDB:1KWX,
FT                   ECO:0007744|PDB:1KWY, ECO:0007744|PDB:1KWZ,
FT                   ECO:0007744|PDB:1KX0, ECO:0007744|PDB:1KX1,
FT                   ECO:0007744|PDB:1RTM, ECO:0007744|PDB:2KMB,
FT                   ECO:0007744|PDB:2MSB, ECO:0007744|PDB:3KMB,
FT                   ECO:0007744|PDB:4KMB"
FT   BINDING         210
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1AFA,
FT                   ECO:0007744|PDB:1AFB, ECO:0007744|PDB:1AFD,
FT                   ECO:0007744|PDB:1BCH, ECO:0007744|PDB:1BCJ,
FT                   ECO:0007744|PDB:1FIF, ECO:0007744|PDB:1FIH,
FT                   ECO:0007744|PDB:1KMB, ECO:0007744|PDB:1KWT,
FT                   ECO:0007744|PDB:1KWU, ECO:0007744|PDB:1KWV,
FT                   ECO:0007744|PDB:1KWW, ECO:0007744|PDB:1KWX,
FT                   ECO:0007744|PDB:1KWY, ECO:0007744|PDB:1KWZ,
FT                   ECO:0007744|PDB:1KX0, ECO:0007744|PDB:1KX1,
FT                   ECO:0007744|PDB:1RTM, ECO:0007744|PDB:2KMB,
FT                   ECO:0007744|PDB:2MSB, ECO:0007744|PDB:3KMB,
FT                   ECO:0007744|PDB:4KMB"
FT   BINDING         210
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1KMB,
FT                   ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU,
FT                   ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW,
FT                   ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY,
FT                   ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0,
FT                   ECO:0007744|PDB:1KX1, ECO:0007744|PDB:1RTM,
FT                   ECO:0007744|PDB:2KMB, ECO:0007744|PDB:2MSB,
FT                   ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB"
FT   BINDING         211
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1AFA,
FT                   ECO:0007744|PDB:1AFB, ECO:0007744|PDB:1AFD,
FT                   ECO:0007744|PDB:1BCH, ECO:0007744|PDB:1BCJ,
FT                   ECO:0007744|PDB:1FIF, ECO:0007744|PDB:1FIH,
FT                   ECO:0007744|PDB:1KMB, ECO:0007744|PDB:1KWT,
FT                   ECO:0007744|PDB:1KWU, ECO:0007744|PDB:1KWV,
FT                   ECO:0007744|PDB:1KWW, ECO:0007744|PDB:1KWX,
FT                   ECO:0007744|PDB:1KWY, ECO:0007744|PDB:1KWZ,
FT                   ECO:0007744|PDB:1KX0, ECO:0007744|PDB:1KX1,
FT                   ECO:0007744|PDB:1RTM, ECO:0007744|PDB:2KMB,
FT                   ECO:0007744|PDB:2MSB, ECO:0007744|PDB:3KMB,
FT                   ECO:0007744|PDB:4KMB"
FT   BINDING         222
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1KMB,
FT                   ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU,
FT                   ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW,
FT                   ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY,
FT                   ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0,
FT                   ECO:0007744|PDB:1KX1, ECO:0007744|PDB:1RTM,
FT                   ECO:0007744|PDB:2KMB, ECO:0007744|PDB:2MSB,
FT                   ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB"
FT   BINDING         223
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:11850428,
FT                   ECO:0000269|PubMed:1436090, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9033386, ECO:0007744|PDB:1KMB,
FT                   ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU,
FT                   ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW,
FT                   ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY,
FT                   ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0,
FT                   ECO:0007744|PDB:1KX1, ECO:0007744|PDB:1RTM,
FT                   ECO:0007744|PDB:2KMB, ECO:0007744|PDB:2MSB,
FT                   ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB"
FT   MOD_RES         43
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         44
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:10903744,
FT                   ECO:0000269|PubMed:25419660"
FT   MOD_RES         47
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:10903744,
FT                   ECO:0000269|PubMed:25419660"
FT   MOD_RES         50
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:25419660"
FT   MOD_RES         61
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         67
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         73
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         78
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         79
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:25419660"
FT   MOD_RES         82
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:25419660"
FT   CARBOHYD        44
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:10903744,
FT                   ECO:0000269|PubMed:25419660"
FT   CARBOHYD        47
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:10903744,
FT                   ECO:0000269|PubMed:25419660"
FT   CARBOHYD        79
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:25419660"
FT   CARBOHYD        82
FT                   /note="O-linked (Gal...) hydroxylysine"
FT                   /evidence="ECO:0000269|PubMed:25419660"
FT   DISULFID        145..234
FT                   /evidence="ECO:0000269|PubMed:1436090,
FT                   ECO:0000269|PubMed:1721241, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9922165, ECO:0007744|PDB:1AFA,
FT                   ECO:0007744|PDB:1AFB, ECO:0007744|PDB:1AFD,
FT                   ECO:0007744|PDB:1BCH, ECO:0007744|PDB:1BCJ,
FT                   ECO:0007744|PDB:1BUU, ECO:0007744|PDB:1FIF,
FT                   ECO:0007744|PDB:1FIH, ECO:0007744|PDB:1KMB,
FT                   ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU,
FT                   ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW,
FT                   ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY,
FT                   ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0,
FT                   ECO:0007744|PDB:1KX1, ECO:0007744|PDB:1MSB,
FT                   ECO:0007744|PDB:1RTM, ECO:0007744|PDB:1YTT,
FT                   ECO:0007744|PDB:2KMB, ECO:0007744|PDB:2MSB,
FT                   ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB"
FT   DISULFID        212..226
FT                   /evidence="ECO:0000269|PubMed:1436090,
FT                   ECO:0000269|PubMed:1721241, ECO:0000269|PubMed:7704532,
FT                   ECO:0000269|PubMed:9922165, ECO:0007744|PDB:1AFA,
FT                   ECO:0007744|PDB:1AFB, ECO:0007744|PDB:1AFD,
FT                   ECO:0007744|PDB:1BCH, ECO:0007744|PDB:1BCJ,
FT                   ECO:0007744|PDB:1BUU, ECO:0007744|PDB:1FIF,
FT                   ECO:0007744|PDB:1FIH, ECO:0007744|PDB:1KMB,
FT                   ECO:0007744|PDB:1KWT, ECO:0007744|PDB:1KWU,
FT                   ECO:0007744|PDB:1KWV, ECO:0007744|PDB:1KWW,
FT                   ECO:0007744|PDB:1KWX, ECO:0007744|PDB:1KWY,
FT                   ECO:0007744|PDB:1KWZ, ECO:0007744|PDB:1KX0,
FT                   ECO:0007744|PDB:1KX1, ECO:0007744|PDB:1MSB,
FT                   ECO:0007744|PDB:1RTM, ECO:0007744|PDB:1YTT,
FT                   ECO:0007744|PDB:2KMB, ECO:0007744|PDB:2MSB,
FT                   ECO:0007744|PDB:3KMB, ECO:0007744|PDB:4KMB"
FT   MUTAGEN         40
FT                   /note="R->C: Prevents higher-order oligomer assembly.
FT                   Slight reduction in secretion rate."
FT                   /evidence="ECO:0000269|PubMed:10903744"
FT   MUTAGEN         42
FT                   /note="G->E: Disrupts homotrimer formation. 5-fold
FT                   reduction in secretion rate. Prevents K-44 hydroxylation
FT                   and glycosylation. 10-fold decrease in complement
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:10903744"
FT   MUTAGEN         44
FT                   /note="K->R: No effect on secretion rate, nor on
FT                   homooligomer formation. 3-fold reduction in secretion rate;
FT                   when associated eith R-47. Prevents higher-order oligomer
FT                   assembly; when associated eith R-47. 10-fold decrease in
FT                   complement activation; when associated eith R-47."
FT                   /evidence="ECO:0000269|PubMed:10903744"
FT   MUTAGEN         45
FT                   /note="G->D: Disrupts homotrimer formation. 5-fold
FT                   reduction in secretion rate. Prevents K-47 hydroxylation
FT                   and glycosylation."
FT                   /evidence="ECO:0000269|PubMed:10903744"
FT   MUTAGEN         47
FT                   /note="K->R: No effect on secretion rate, nor on
FT                   homooligomer formation. 3-fold reduction in secretion rate;
FT                   when associated eith R-44. Prevents higher-order oligomer
FT                   assembly; when associated eith R-44. 10-fold decrease in
FT                   complement activation; when associated eith R-44."
FT                   /evidence="ECO:0000269|PubMed:10903744"
FT   MUTAGEN         228..230
FT                   /note="ASH->KKK: Changes carbohydrate binding specificity,
FT                   leading to interaction with Lewis blood group antigens."
FT                   /evidence="ECO:0000269|PubMed:9033386"
FT   CONFLICT        156
FT                   /note="R -> K (in Ref. 2; AAA98781)"
FT                   /evidence="ECO:0000305"
FT   HELIX           91..119
FT                   /evidence="ECO:0007829|PDB:1RTM"
FT   STRAND          128..136
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   HELIX           138..147
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:1BUU"
FT   HELIX           158..168
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   STRAND          172..181
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   STRAND          184..187
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   STRAND          190..192
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   STRAND          198..202
FT                   /evidence="ECO:0007829|PDB:1BUU"
FT   STRAND          212..215
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   HELIX           217..219
FT                   /evidence="ECO:0007829|PDB:1RTM"
FT   STRAND          221..224
FT                   /evidence="ECO:0007829|PDB:2MSB"
FT   STRAND          230..236
FT                   /evidence="ECO:0007829|PDB:2MSB"
SQ   SEQUENCE   238 AA;  25308 MW;  1A927482B8A8CB3D CRC64;
     MLLLPLLVLL CVVSVSSSGS QTCEETLKTC SVIACGRDGR DGPKGEKGEP GQGLRGLQGP
     PGKLGPPGSV GAPGSQGPKG QKGDRGDSRA IEVKLANMEA EINTLKSKLE LTNKLHAFSM
     GKKSGKKFFV TNHERMPFSK VKALCSELRG TVAIPRNAEE NKAIQEVAKT SAFLGITDEV
     TEGQFMYVTG GRLTYSNWKK DEPNDHGSGE DCVTIVDNGL WNDISCQASH TAVCEFPA
//
